Clinicly Sp. z o.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Peripheral artery disease1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Zenas BioPharma (USA), LLC2 trials
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· Phase 3· Zenas BioPharma (USA), LLC· Source

• Recruiting

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· Phase 3· Zenas BioPharma (USA), LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis2 recruiting
• Peripheral artery disease1 recruiting